Epithalon

Epithalon (Epitalon)

A tetrapeptide derived from the pineal gland that activates telomerase and has demonstrated lifespan extension in multiple animal models.

100% 50% · t½ Time → Serum level
Molecular Weight
390.35 Da
Half-Life
~2 hours
Typical Dose
5–10 mg daily
Cycle Length
10 days, 1–2x per year

Description

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from Epithalamin, a natural polypeptide extract of the pineal gland. It was developed by the St. Petersburg Institute of Bioregulation and Gerontology under the direction of Professor Vladimir Khavinson, who has published extensively on its effects in aging research. Epithalon is best known for its ability to activate telomerase — the enzyme responsible for maintaining telomere length — and has been studied in the context of longevity, cancer prevention, and circadian rhythm regulation. Animal studies have shown life extension of 20–30% in rodents, and human studies (primarily from Russian research groups) have reported improvements in various biomarkers of aging. It also regulates melatonin production and has demonstrated antioxidant and immunomodulatory properties.

Key Characteristics

Molecular FormulaC14H22N4O9
Molecular Weight390.35 Da
Half-Life~2 hours
Administration RoutesSubcutaneous injection, Intravenous (clinical setting), Intranasal
Typical Dose5–10 mg daily
FrequencyDaily (10-day course)

Investigated Benefits

  • Telomere elongation
  • Telomerase activation
  • Improved melatonin production
  • Potential lifespan extension
  • Reduced cancer incidence (animal models)
  • Antioxidant effects

* Benefits based on preclinical/animal research unless otherwise noted.